NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

2. When Sawston is certified that gives 45-50 patients/month who can get DCVax in the UK at Dr. Ashkan’s clinic. Unlike in the US, where a treatment’s manufacturer cannot profit, the UK allows it. At $125K-$150K/patient/month we’ll immediately start seeing revenues of $18,750,000 to $22,500,000 per quarter while we await approvals.

At end of 2019 the revenue was over $600K/q. It dropped to $0 in Q2 2020 with Covid. Since then it has been slowly recovering and is at $240K in Q1. Up from $215K in Q3 2020.

In short, not even close to being capacity limited. And you expect it to jump 80 fold just because they have a new manufacturing facility when they old run was not at capacity. Kind of like the joke about the bigger pickup.

BTW, getting flaskworks certified for commercial production will not happen for years.